杨苏瓃鑫
个人信息
杨苏瓃鑫，药物化学课题组组长，生物医药博士，立即博备用网址_立即博赌场-游戏平台中医药创新研究院特聘副研究员。2024年毕业于澳门大学中华医药研究院。主要研究方向为纳米药物/基因递送系统开发，已发表SCI论文十余篇，Google Scholar总引用>680次；其中以第一/共同第一作者发表论文5篇，包括Advanced Materials、Acta Biomaterialia、Journal of Controlled Release、Theranostics等。
联系方式
邮箱：yangsulation@qq.com
代表性成果
1. Yang S#, Wu Y#, Zhong W, Chen R, Wang M, Chen M*. GSH/pH Dual Activatable Crosslinked and Fluorinated PEI for Cancer Gene Therapy through Endogenous Iron De-Hijacking and in situ ROS Amplification[J]. Advanced Materials, adma.202304098.
2. Yang S#, Wong K#, Hua P#, He C, Yu H, Shao D, Shi Z, Chen M*. ROS-Responsive Fluorinated Polyethyleneimine Vector to Co-deliver shMTHFD2 and shGPX4 Plasmids Induces Ferroptosis and Apoptosis for Cancer Therapy[J]. Acta Biomaterialia, 2022, 140: 492-505.
3. Yang S#, Ou C#, Wang L#, Liu X, Yang J, Wang X, Wang M, Shen M, Wu Q, Gong C*. Virus-esque Nucleus-Targeting Nanoparticles Deliver Trojan Plasmid for Release of Anti-Tumor Shuttle Protein[J]. Journal of Controlled Release, 2020, 320: 253-264.
5. Liu X#, Yang S#, Wang L#, Wu X, Wang X, Ou C, Yang J, Song L, Zhou S, Wu Q*, Gong C*. Hierarchically Tumoractivated nanoCRISPR-Cas13a Facilitates Efficient microRNA Disruption for Multi-Pathway-Mediated Tumor Suppression[J]. Theranostics, 2023; 13(9): 2774-2786.
6. Li L#, Yang S#, Song L, Zeng Y, He T, Wang N, Yu C, Yin T, Liu L, Wei X, Wei Y, Yang L, Gong C*. An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy[J]. Theranostics, 2018, 8(3): 860.
7. Yang S, Wu Q, Wei Y, Gong C*. CRISPR-Cas9 delivery by artificial virus (RRPHC)[M]//CRISPR Gene Editing. Humana Press, New York, NY, 2019: 81-91.